146 related articles for article (PubMed ID: 24687531)
1. Combination chemotherapy of low-dose 5-fluorouracil and cisplatin for advanced extramammary Paget's disease.
Tokuda Y; Arakura F; Uhara H
Int J Clin Oncol; 2015 Feb; 20(1):194-7. PubMed ID: 24687531
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of low-dose 5-fluorouracil/cisplatin therapy for invasive extramammary Paget's disease.
Kato H; Watanabe S; Kariya K; Nakamura M; Morita A
J Dermatol; 2018 May; 45(5):560-563. PubMed ID: 29446148
[TBL] [Abstract][Full Text] [Related]
3. Trial of low-dose 5-fluorouracil/cisplatin therapy for advanced extramammary Paget's disease.
Kariya K; Tsuji T; Schwartz RA
Dermatol Surg; 2004 Feb; 30(2 Pt 2):341-4. PubMed ID: 14871231
[TBL] [Abstract][Full Text] [Related]
4. [A case of vulval extramammary Paget's disease associated with pancreatic cancer that was successfully treated with chemotherapy].
Onishi I; Kamata T; Hayashi H; Hayashi Y; Minatoya G; Michiwa Y; Takeda T; Kanno M; Takeda K
Gan To Kagaku Ryoho; 2002 Nov; 29(11):1973-6. PubMed ID: 12465398
[TBL] [Abstract][Full Text] [Related]
5. Low-dose 5-fluorouracil/cisplatin therapy as conversion chemotherapy for advanced extramammary Paget's disease.
Nakamura K; Nakamura M; Kato H; Morita A
Kaohsiung J Med Sci; 2020 Apr; 36(4):287-288. PubMed ID: 31868989
[No Abstract] [Full Text] [Related]
6. A case of metastatic extramammary Paget's disease that responded to combination chemotherapy.
Yamazaki N; Yamamoto A; Wada T; Ishikawa M; Moriya Y; Nakanishi Y
J Dermatol; 1999 May; 26(5):311-6. PubMed ID: 10380432
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy of advanced adenocarcinoma of the skin].
Yamazaki N
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1302-7. PubMed ID: 8394060
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel induced durable response in advanced extramammary Paget's disease: a case report.
Oguchi S; Kaneko M; Uhara H; Saida T
J Dermatol; 2002 Jan; 29(1):33-7. PubMed ID: 11837572
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of metastatic extramammary Paget's disease with pemetrexed monotherapy systemically and 5-fluorouracil topically.
Chen K; Liang H; Peng J; Zheng Y
Indian J Dermatol Venereol Leprol; 2019; 85(1):56-59. PubMed ID: 29536970
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy for advanced adenocarcinoma of the skin: experience with combination chemotherapy and a review of the literature].
Yamazaki N
Gan To Kagaku Ryoho; 1997 Jan; 24(1):30-6. PubMed ID: 9020942
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel Combined With Cisplatin for Metastatic Extramammary Paget Disease.
Cai H; Xu W; Yu B; Li X; Zhu L; Xu Z; Zhou J; Zheng Y; Zou Q; Zeng Y; Wang X; Xu T
Clin Genitourin Cancer; 2018 Aug; 16(4):e899-e901. PubMed ID: 29685612
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer.
Kim R; Murakami S; Ohi Y; Inoue H; Yoshida K; Toge T
Int J Oncol; 1999 Nov; 15(5):921-6. PubMed ID: 10536174
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer.
Honecker F; Kollmannsberger C; Quietzsch D; Haag C; Schroeder M; Spott C; Hartmann JT; Baronius W; Hempel V; Kanz L; Bokemeyer C
Anticancer Drugs; 2002 Jun; 13(5):497-503. PubMed ID: 12045461
[TBL] [Abstract][Full Text] [Related]
14. Concurrent chemoradiotherapy for esophageal cancer: comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil.
Sai H; Mitsumori M; Yamauchi C; Araki N; Okumura S; Nagata Y; Nishimura Y; Hiraoka M
Int J Clin Oncol; 2004 Jun; 9(3):149-53. PubMed ID: 15221597
[TBL] [Abstract][Full Text] [Related]
15. Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma.
Chung YS; Yamashita Y; Inoue T; Matsuoka T; Nakata B; Onoda N; Maeda K; Sawada T; Kato Y; Shirasaka T; Sowa M
Cancer; 1997 Jul; 80(1):1-7. PubMed ID: 9210702
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy for metastatic extramammary Paget disease.
Oashi K; Tsutsumida A; Namikawa K; Tanaka R; Omata W; Yamamoto Y; Yamazaki N
Br J Dermatol; 2014 Jun; 170(6):1354-7. PubMed ID: 24329551
[TBL] [Abstract][Full Text] [Related]
17. Low-dose mitomycin C, etoposide, and cisplatin for invasive vulvar Paget's disease.
Watanabe Y; Hoshiai H; Ueda H; Nakai H; Obata K; Noda K
Int J Gynecol Cancer; 2002; 12(3):304-7. PubMed ID: 12060453
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of DLF, CLF and DFM regimens based on platinum compound plus 5-fluorouracil for treatment of advanced esophageal carcinoma].
Jiang Y; Qiu XH; Yang YX; Zhang SQ; Chen ZM
Ai Zheng; 2006 Aug; 25(8):1029-34. PubMed ID: 16965688
[TBL] [Abstract][Full Text] [Related]
19. Docetaxel and Cisplatin Plus Fluorouracil compared with Modified Docetaxel, Cisplatin, and 5-Fluorouracil as first-line therapy for advanced gastric cancer: a retrospective analysis of single institution.
Inal A; Kaplan MA; Kucukoner M; Isikdogan A
Neoplasma; 2012; 59(2):233-6. PubMed ID: 22248282
[TBL] [Abstract][Full Text] [Related]
20. Anal canal adenocarcinoma with neuroendocrine features accompanying secondary extramammary Paget disease, successfully treated with modified FOLFOX6: a case report.
Yamaura M; Yamada T; Watanabe R; Kawai H; Hirose S; Tajima H; Sato M; Uchida Y; Suganuma D; Yamamoto Y; Moriwaki T; Hyodo I
BMC Cancer; 2018 Nov; 18(1):1142. PubMed ID: 30458812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
